Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 1/2011

Open Access 01-01-2011 | Original paper

Injection Drug Use as a Mediator Between Client-perpetrated Abuse and HIV Status Among Female Sex Workers in Two Mexico-US Border Cities

Authors: Monica D. Ulibarri, Steffanie A. Strathdee, Emilio C. Ulloa, Remedios Lozada, Miguel A. Fraga, Carlos Magis-Rodríguez, Adela De La Torre, Hortensia Amaro, Patricia O’Campo, Thomas L. Patterson

Published in: AIDS and Behavior | Issue 1/2011

Login to get access

Abstract

We examined relationships between client-perpetrated emotional, physical, and sexual abuse, injection drug use, and HIV-serostatus among 924 female sex workers (FSWs) in Tijuana and Ciudad Juarez, two large Mexico-US border cities. We hypothesized that FSWs’ injection drug use would mediate the relationship between client-perpetrated abuse and HIV-seropositivity. The prevalence of client-perpetrated emotional, physical, and sexual abuse in the past 6 months was 26, 18, and 10% respectively; prevalence of current injection drug use and HIV was 12 and 6%, respectively. Logistic regression analyses revealed that client-perpetrated sexual abuse was significantly associated with HIV-seropositivity and injection drug use, and that injection drug use was positively associated with HIV-seropositivity. Injection drug use partially mediated the relationship between client-perpetrated sexual abuse and HIV-seropositivity. Results suggest the need to address client-perpetrated violence and injection drug use when assessing HIV risk among FSWs.
Literature
1.
Singer M. A dose of drugs, a touch of violence, a case of AIDS: conceptualizing the SAVA syndemic. Free Inq Creat Sociol. 1996;24(2):99–110.
2.
Singer M. AIDS and the health crisis of the US urban poor: the perspective of critical medical anthropology. Soc Sci Med. 1994;39(7):931–48.CrossRefPubMed
3.
CENSIDA. Panorama Epidemiologico del VIH/SIDA e ITS en Mexico: centro Nacional para la Prevencion y Control del VIH/SIDA2006 June 30 2006.
4.
5.
6.
Bucardo J, Brouwer KC, Magis-Rodriguez C, Ramos R, Fraga M, Perez SG, et al. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend. 2005;79(3):281–93.CrossRefPubMed
7.
Strathdee SA, Lozada R, Semple SJ, Orozovich P, Pu M, Staines-Orozco H, et al. Characteristics of female sex workers with US clients in two Mexico-US border cities. Sex Transm Dis. 2008;35(3):263–8.CrossRefPubMed
8.
Bucardo J, Semple SJ, Fraga-Vallejo M, Davila W, Patterson TL. A qualitative exploration of female sex work in Tijuana, Mexico. Arch Sex Behav. 2004;33(4):343–51.CrossRefPubMed
9.
Amaro H. Love, sex, and power: considering women’s realities in HIV prevention. Am Psychol. 1995;50(6):437–47.CrossRefPubMed
10.
Maman S, Campbell J, Sweat MD, Gielen AC. The intersections of HIV and violence: directions for future research and interventions. Soc Sci Med. 2000;50(4):459–78.CrossRefPubMed
11.
Gonzalez-Guarda RM, Peragallo N, Urrutia MT, Vasquez EP, Mitrani VB. HIV risks, substance abuse, and intimate partner violence among Hispanic women and their intimate partners. J Assoc Nurses AIDS Care. 2008;19(4):252–66.CrossRefPubMed
12.
Silverman JG, Decker MR, Saggurti N, Balaiah D, Raj A. Intimate partner violence and HIV infection among married Indian women. JAMA. 2008;300(6):703–10.CrossRefPubMed
13.
Sormanti M, Shibusawa T. Intimate partner violence among midlife and older women: a descriptive analysis of women seeking medical services. Health Soc Work. 2008;33(1):33–41.PubMed
14.
El-Bassel N, Gilbert L, Wu E, Chang M, Gomes C, Vinocur D, et al. Intimate partner violence prevalence and HIV risks among women receiving care in emergency departments: implications for IPV and HIV screening. Emerg Med J. 2007;24(4):255–9.CrossRefPubMed
15.
Sanders T. Female street workers, sexual violence, and protection strategies. J Sex Aggress. 2001;7(1):5–18.CrossRef
16.
Shannon K, Kerr T, Bright V, Gibson K, Tyndall MW. Drug sharing with clients as a risk marker for increased violence and sexual and drug-related harms among survival sex workers. AIDS Care. 2008;20(2):228–34.CrossRefPubMed
17.
Wechsberg WM, Luseno WK, Lam WK. Violence against substance-abusing South African sex workers: intersection with culture and HIV risk. AIDS Care. 2005;17:S55–64.CrossRefPubMed
18.
Panchanadeswaran S, Johnson SC, Sivaram S, Srikrishnan AK, Latkin C, Bentley ME, et al. Intimate partner violence is as important as client violence in increasing street-based female sex workers’ vulnerability to HIV in India. Int J Drug Policy. 2008;19(2):106–12.CrossRefPubMed
19.
Surratt H. Sex work in the Caribbean Basin: patterns of substance use and HIV risk among migrant sex workers in the US Virgin Islands. AIDS Care. 2007;19(10):1274–82.CrossRefPubMed
20.
El-Bassel N, Witte SS, Wada T, Gilbert L, Wallace J. Correlates of partner violence among female street-based sex workers: substance abuse, history of childhood abuse, and HIV risks. AIDS Patient Care STDS. 2001;15(1):41–51.CrossRefPubMed
21.
Miller M. A model to explain the relationship between sexual abuse and HIV risk among women. AIDS Care. 1999;11(1):3–20.CrossRefPubMed
22.
Wagner KD, Hudson SM, Latka MH, Strathdee SA, Thiede H, Mackesy-Amiti ME, et al. The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav. 2009;13:217–24.CrossRefPubMed
23.
Braitstein P, Li K, Tyndall M, Spittal P, O’Shaughnessy MV, Schilder A, et al. Sexual violence among a cohort of injection drug users. Soc Sci Med. 2003;57(3):561–9.CrossRefPubMed
24.
Strathdee SA, Patrick DM, Archibald CP, Ofner M, Cornelisse PG, Rekart M, et al. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction. 1997;92(10):1339–47.PubMed
25.
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173–82.CrossRefPubMed
26.
Patterson TL, Semple SJ, Fraga M, Bucardo J, De la Torre A, Salazar-Reyna J, et al. A sexual risk reduction intervention for female sex workers in Mexico: design and baseline characteristics. J HIV AIDS Soc Serv. 2006;5(2):115–37.CrossRef
27.
Patterson TL, Semple SJ, Fraga M, Bucardo J, Davila-Fraga W, Strathdee SA. An HIV-prevention intervention for sex workers in Tijuana, Mexico: a pilot study. Hisp J Behav Sci. 2005;27(1):82–100.CrossRef
28.
McLellan AT, Kushner H, Metzger D, Peters R. The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992;9(3):199–213.CrossRefPubMed
29.
Sobel ME. Asymptotic confidence intervals for indirect effects in structural equations models. In: Leinhart S, editor. Sociological methodology. San Francisco: Jossey-Bass; 1982. p. 290–312.
30.
Strathdee SA, Philbin MM, Semple SJ, Pu M, Orozovich P, Martinez G, et al. Correlates of injection drug use among female sex workers in two Mexico-US border cities. Drug Alcohol Depend. 2008;92(1–3):132–40.CrossRefPubMed
31.
Patterson TL, Semple SJ, Staines H, Lozada R, Orozovich P, Philbin MM, et al. Prevalence and correlates of HIV infection among female sex workers in two Mexico-US border cities. J Infect Dis. 2008;197:728–32.CrossRefPubMed
32.
Choi SYP, Holroyd E. The influence of power, poverty and agency in the negotiation of condom use for female sex workers in mainland China. Cult Health Sex. 2007;9(5):489–503.CrossRefPubMed
33.
Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med. 2008;66(4):911–21.CrossRefPubMed
34.
Surratt HL, Kurtz SP, Weaver JC, Inciardi JA. The connections of mental health problems, violent life experiences, and the social milieu of the ‘stroll’ with the HIV risk behaviors of female street sex workers. J Psychol Hum Sex. 2005;17(1):23–44.CrossRef
35.
Cruz MF, Mantsios A, Ramos R, Case P, Brouwer KC, Ramos ME, et al. A qualitative exploration of gender in the context of injection drug use in two US-Mexico border cities. AIDS Behav. 2007;11(2):253–62.CrossRefPubMed
36.
Harvey E, Strathdee SA, Patrick DM, Ofner M, Archibald CP, Eades G, et al. A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. AIDS Care. 1998;10(3):313–21.CrossRefPubMed
37.
Andrade R, Estrada AL. Are Hispana IDUs Tecatas?: reconsidering gender and culture in Hispana injection drug use. Subst Use Misuse. 2003;38(8):1133–58.CrossRefPubMed
38.
Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80(4 (suppl 3)):iii7–14.PubMed
39.
Darke S, Hall W, Heather N, Ward J. The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. AIDS. 1991;5(2):181–5.CrossRefPubMed
40.
De Irala J, Bigelow C, McCusker J, Hindin R, Zheng L. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. Am J Epidemiol. 1996;143(7):725–32.PubMed
41.
Van Duynhoven YT, Nagelkerke NJ, Van De Laar MJ. Reliability of self-reported sexual histories: test-retest and interpartner comparison in a sexually transmitted diseases clinic. Sex Transm Dis. 1999;26(1):33–42.CrossRefPubMed
42.
Amaro H, Larson MJ, Zhang A, Acevedo A, Dai J, Matsumoto A. Effects of trauma intervention on HIV sexual risk behaviors among women with co-occurring disorders in substance abuse treatment. J Commun Psychol. 2007;35(7):895–908.CrossRef
Metadata
Title
Injection Drug Use as a Mediator Between Client-perpetrated Abuse and HIV Status Among Female Sex Workers in Two Mexico-US Border Cities
Authors
Monica D. Ulibarri
Steffanie A. Strathdee
Emilio C. Ulloa
Remedios Lozada
Miguel A. Fraga
Carlos Magis-Rodríguez
Adela De La Torre
Hortensia Amaro
Patricia O’Campo
Thomas L. Patterson
Publication date
01-01-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-009-9595-1

Other articles of this Issue 1/2011

AIDS and Behavior 1/2011 Go to the issue

Original Paper

Sexual Serosorting among Women with or at Risk of HIV Infection

Original Paper

Racial/Ethnic Differences in Seroadaptive and Serodisclosure Behaviors Among Men Who Have Sex with Men

Original Paper

Reducing HIV-Related Risk Behaviors Among Injection Drug Users in Residential Detoxification

Original Paper

HIV Incidence and Prevalence Among Aboriginal Peoples in Canada

Original Paper

HIV Disclosure, Condom Use, and Awareness of HIV Infection Among HIV-Positive, Heterosexual Drug Injectors in St. Petersburg, Russian Federation

Original Paper

Behavioral Surveillance of Knowledge About HIV/AIDS Transmission and Perceived Need for Additional Knowledge in a National Sample of Young Israeli Men and Women Between 1993 and 2005
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits